The diagnosis and medical management of advanced neuroendocrine tumors.
The DOI matches its Crossref record; 657 of the 670 references it cites were found in a registry or an index.
Abstract
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endocrine glands such as the pituitary, the parathyroids, and the (neuroendocrine) adrenal, as well as endocrine islets within glandular tissue (thyroid or pancreatic) and cells dispersed between exocrine cells, such as endocrine cells of the digestive (gastroenteropancreatic) and respiratory tracts. Conventionally, NETs may present with a wide variety of functional or nonfunctional endocrine syndromes and may be familial and have other associated tumors. Assessment of specific or general tumor markers offers high sensitivity in establishing the diagnosis and can also have prognostic significance. Imaging modalities include endoscopic ultrasonography, computed tomography and magnetic resonance imaging, and particularly, scintigraphy with somatostatin analogs and metaiodobenzylguanidine. Successful treatment of disseminated NETs requires a multimodal approach; radical tumor surgery may be curative but is rarely possible. Well-differentiated and slow-growing gastroenteropancreatic tumors should be treated with somatostatin analogs or alpha-interferon, with chemotherapy being reserved for poorly differentiated and progressive tumors. Therapy with radionuclides may be used for tumors exhibiting uptake to a diagnostic scan, either after surgery to eradicate microscopic residual disease or later if conventional treatment or biotherapy fails. Maintenance of the quality of life should be a priority, particularly because patients with disseminated disease may experience prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the combination of noninvasive and selected invasive modalities (particularly endoscopic ultrasound), most insulinomas are localized preoperatively (72, 78).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
In the citing paper
“Although the results with a given method reflect the experience and expertise with that method at a given center, computed tomography, MRI, and transabdominal ultrasonography detect most insulinomas (71-73).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
Citations
Cites
Items 401–600 of 657
Management of Carcinoid Tumors of the Stomach, Duodenum, and Pancreas
Åkerström, G. (1996) · World Journal of Surgery · doi:10.1007/s002689900027 · Cited by 73
Carcinoids of unknown origin: Comparative analysis with foregut, midgut, and hindgut carcinoids
Kirshbom, P. M., Kherani, A. R., Onaitis, M. W., Feldman, J. M., & Tyler, D. S. (1998) · Surgery · doi:10.1067/msy.1998.93105 · Cited by 73
Increased Expression of Cyclooxygenase-2 in Malignant Pheochromocytomas
Salmenkivi, K., Haglund, C. H., Ristimaki, A. P., Arola, J. T., & Heikkilä, P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8052 · Cited by 73
Benign and Malignant Pheochromocytoma
Kebebew, E., & Duh, Q. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30244-8 · Cited by 73
Islet cell carcinoma of the pancreas. A study of 98 patients
Venkatesh, S., Ordóǹez, N. G., Ajani, J. A., Schultz, P. N., Hickey, R. C., Johnston, D. A., & Samaan, N. A. (1990) · Cancer · doi:10.1002/1097-0142(19900115)65:2<354::aid-cncr2820650229>3.0.co;2-n · Cited by 73
Jacobsen, M. B., Hanssen, L. E., Kolmannskog, F., Schrumpf, E., Vatn, M. H., & Bergan, A. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509096329 · Cited by 71
Somatostatinoma: A case report and review of the literature
Harris, G. J., Tio, F. O., & Cruz, A. B. (1987) · Journal of Surgical Oncology · doi:10.1002/jso.2930360104 · Cited by 71
Shapiro, B., Sisson, J. C., Wieland, D. M., Mangner, T. J., Zempel, S., Mudgett, E. E., Gross, M. D., Carey, J. E., Zasadny, K. R., & Beierwaltes, W. H. (1991) · PubMed · Cited by 71
D�rr, U., R�th, U., Sautter‐Bihl, M., Guzman, G., Bach, G., Adrian, H.-J., & Bihl, H. (1993) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00209003 · Cited by 70
Proye, C., Vix, M., Goropoulos, A., Kerlo, P., & Lecomte-Houcke, M. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03345810 · Cited by 70
Kaltsas, G., Mukherjee, J. J., & Grossman, A. B. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s47 · Cited by 70
Self-citationManagement of Nonfunctioning Islet Cell Carcinomas
Bartsch, D. K., Schilling, T., Ramaswamy, A., Gerdes, B., Celik, I., Wagner, H., Simon, B., & Rothmund, Μ. (2000) · World Journal of Surgery · doi:10.1007/s002680010234 · Cited by 69
Kopf, D., Bockisch, A., Steinert, H. C., Hahn, K. M., Beyer, J., Neumann, H. P. H., Hensen, J., & Lehnert, H. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1738.x · Cited by 69
Recent advances in carcinoid pathogenesis, diagnosis and management
Ganim, R. B., & Norton, J. A. (2000) · Surgical Oncology · doi:10.1016/s0960-7404(01)00007-x · Cited by 69
Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
Välimäki, M. J., Järvinen, H., Salmela, P. I., Sane, T., Sjöblom, S. M., & Pelkonen, R. (1991) · Cancer · doi:10.1002/1097-0142(19910201)67:3<547::aid-cncr2820670302>3.0.co;2-j · Cited by 68
Interventional Treatment of Gastrointestinal Neuroendocrine Tumours
Ahlman, H. K., Wängberg, B., Jansson, S., Friman, S., Olausson, M., Tylén, U., & Nilsson, O. (2000) · Digestion · doi:10.1159/000051857 · Cited by 67
Radioactive Iodine in the Treatment of Medullary Carcinoma of the Thyroid*
Saad, M. F., Guido, J. J., & Samaan, N. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-1-124 · Cited by 67
The Use of Chemotherapy in the Management of Neuroendocrine Tumors
Öberg, K. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30142-7 · Cited by 67
Grant, C. S. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90017-2 · Cited by 66
Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma
Kao, P. C. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1048 · Cited by 65
Connolly, H. M., Schaff, H. V., Mullany, C. J., Abel, M., & Pellikka, P. A. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)01068-1 · Cited by 65
Elevated levels of telomerase activity in malignant pheochromocytoma
Kubota, Y., Nakada, T., Sasagawa, I., Yanai, H., & Itoh, K. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980101)82:1<176::aid-cncr22>3.0.co;2-z · Cited by 65
Lupoli, G., Cascone, E., Arlotta, F., Vitale, G., Celentano, L., Salvatore, M., & Lombardi, G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960901)78:5<1114::aid-cncr23>3.0.co;2-4 · Cited by 65
Sugimoto, E., Lörelius, L., Eriksson, B. K., & Öberg, K. (1995) · Acta Radiologica · doi:10.1080/02841859509173390 · Cited by 64
Leong, W. L., & Pasieka, J. L. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10062 · Cited by 63
Pretargeting using peptide nucleic acid
Rusckowski, M., Qu, T., Chang, F., & Hnatowich, D. J. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971215)80:12+<2436::aid-cncr16>3.0.co;2-d · Cited by 63
Imaging of incidentally discovered adrenal masses
Peppercorn, P. D., Grossman, A. B., & Reznek, R. H. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00475.x · Cited by 62
Self-citationZollinger-Ellison Syndrome: Advances in Treatment of Gastric Hypersecretion and the Gastrinoma
Jensen, R. T. (1994) · JAMA · doi:10.1001/jama.271.18.1429 · Cited by 62
Hanssen, L. E., Schrumpf, E., Kolbenstvedt, A., Tausjø, J., & Dolva, L. Ø. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909089215 · Cited by 62
Solcia, E., Rindi, G., Paolotti, D., Rosa, S. L., Capella, C., & Fiocca, R. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s9 · Cited by 62
Moley, J. F. (2003) · Current Treatment Options in Oncology · doi:10.1007/s11864-003-0009-8 · Cited by 61
Brändle, M., Pfammatter, T., Spinas, G. A., Lehmann, R., & Schmid, C. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01335.x · Cited by 61
Wynick, D., Anderson, J. V., Williams, S. J., & Bloom, S. R. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00436.x · Cited by 60
A "Pheo" Lurks: Novel Approaches for Locating Occult Pheochromocytoma
Pacak, K. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3641 · Cited by 60
Advances in chemotherapy and biotherapy of endocrine tumors
Öberg, K. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199801000-00010 · Cited by 59
Benign and malignant pheochromocytoma: diagnosis, treatment, and follow-Up.
Kebebew, E., & Duh, Q. (1998) · PubMed · Cited by 59
131I-MIBG therapy of neural crest tumours (review).
Troncone, L., & Rufini, V. (1997) · PubMed · Cited by 59
Kälkner, K. M., Janson, E. T., Nilsson, S. F., Carlsson, S., Öberg, K., & Westlin, J. E. (1995) · PubMed · Cited by 58
Stroh, T., Jackson, A. C., Sarret, P., Farra, C. D., Vincent, J., Kreienkamp, H., Mazella, J., & Beaudet, A. (2000) · Endocrinology · doi:10.1210/endo.141.1.7259 · Cited by 58
Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism.
Kaczirek, K., Soleiman, A., Schindl, M., Passler, C., Scheuba, C., Prager, G., Kaserer, K., & Niederle, B. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01158.x · Cited by 57
Use of octreotide acetate for control of symptoms in patients with islet cell tumors
Maton, P. N. (1993) · World Journal of Surgery · doi:10.1007/bf01655110 · Cited by 57
Nicholson, J., VAUGHN, E. D., PICKERING, T. G., RESNICK, L. M., ARTUSIO, J., KLEINERT, H. D., LOPEZ-OVERJERO, J. A., & LARAGH, J. H. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-4-477 · Cited by 57
Necrolytic migratory erythema: clinicopathologic study of 13 cases
Pujol, R. M., Wang, C. E., el‐Azhary, R. A., Su, W. P. D., Gibson, L. E., & Schroeter, A. L. (2003) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2004.01844.x · Cited by 57
The Role of Radiation Therapy in Medullary Carcinoma of the Thyroid
Steinfeld, A. D. (1977) · Radiology · doi:10.1148/123.3.745 · Cited by 56
Tanaka, S., Ito, T., Tomoda, J., Higashi, T., Yamada, G., & Tsuji, T. (1993) · Internal Medicine · doi:10.2169/internalmedicine.32.789 · Cited by 56
Localization, Malignant Potential, and Surgical Management of Gastrinomas
Kisker, O., Bastian, D., Bartsch, D. K., Nies, C., & Rothmund, Μ. (1998) · World Journal of Surgery · doi:10.1007/s002689900448 · Cited by 55
Treatment of Neuroendocrine Tumours in Adults with 131I-MIBG Therapy
Bomanji, J. B., Wong, W., Gaze, M. N., Cassoni, A., Waddington, W., Solano, J., & Ell, P. J. (2003) · Clinical Oncology · doi:10.1016/s0936-6555(02)00273-x · Cited by 55
Connolly, H. M., Schaff, H. V., Mullany, C. J., Abel, M., & Pellikka, P. A. (2002) · Circulation · doi:10.1161/01.cir.0000032884.55215.87 · Cited by 55
Gastrointestinal endocrine tumours
O'Shea, D. B., & Bloom, S. R. (1996) · Baillière Tindall eBooks · Cited by 54
London, J. F., Shawker, T. H., Doppman, J. L., Frucht, H., Vinayek, R., Stark, H. A., Miller, L. S., Miller, D. L., Norton, J. A., & Jensen, R. T. (1991) · Radiology · doi:10.1148/radiology.178.3.1994415 · Cited by 54
Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction)
Cohen, C. D., & DENT, D. M. (1984) · Postgraduate Medical Journal · doi:10.1136/pgmj.60.700.111 · Cited by 54
Mao, C., Attar, A. E., Domenico, D. R., Kim, K., & Howard, J. M. (1998) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:23:2:153 · Cited by 54
Lamarre-Cliché, M., Gimenez‐Roqueplo, A., Billaud, E. M., Baudin, É., LUTON, J. P., & Plouin, P. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01658.x · Cited by 54
Gasparoni, P., Rubello, D., & Ferlin, G. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03348014 · Cited by 52
Inhibin/Activin B-Subunit Expression in Pheochromocytomas Favors Benign Diagnosis
Salmenkivi, K., Arola, J. T., Voutilainen, R., Ilvesmäki, V., Haglund, C., Kahri, A. I., Heikkilä, P., & Liu, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7446 · Cited by 52
Cadiot, G., Bonnaud, G., Lebtahi, R., Sarda‐Mantel, L., Ruszniewski, P. B., Guludec, D. L., & Mignon, M. (1997) · Gut · doi:10.1136/gut.41.1.107 · Cited by 52
Schirmer, W. J., Melvin, W. S., Rush, R. M., O’Dorisio, T. M., Pozderac, R. V., Olsen, J. O., & Ellison, E. C. (1995) · Surgery · doi:10.1016/s0039-6060(05)80121-7 · Cited by 52
Castellani, M. R., Chiti, A., Seregni, E. C., & Bombardieri, E. (2000) · PubMed · Cited by 52
Drug Therapy in Metastatic Neuroendocrine Tumors of the Gastroenteropancreatic System
Faiss, S., Scherübl, H., Riecken, E. O., & Wiedenmann, B. (1996) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-80035-1_12 · Cited by 51
Clinical aspects of glucagon-producing islet cell tumors.
Prinz, R. A., Dorsch, T. R., & Lawrence, A. M. (1981) · PubMed · Cited by 51
The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours
Kaltsas, G., Mukherjee, J. J., Plowman, P. N., & Grossman, A. B. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01396.x · Cited by 51
Self-citationDiagnosis and Treatment of VIPoma in China
Peng, S.-Y., Li, J. T., Liu, Y. B., Fang, H. Q., Wu, Y., Peng, C. H., Wang, X. B., & Qian, H. R. (2003) · Pancreas · doi:10.1097/00006676-200401000-00015 · Cited by 51
Usefulness of Chromogranin A as a Marker for Detection of Relapses of Carcinoid Tumours
Pirker, R. A., Pont, J., Pöhnl, R., Schütz, W., Griesmacher, A., & Müller, M. M. (1998) · cclm · doi:10.1515/cclm.1998.147 · Cited by 51
Eriksson, B., Janson, E. T., Bax, N. D. S., Mignon, M., Morant, R., Opolon, P., Rougier, P. R., & Öberg, K. E. (2009) · Digestion · doi:10.1159/000201402 · Cited by 51
Plouin, P., Bertherat, J. Y., Chateiller, O., Billaud, E. M., Azizi, M., Grouzmann, E., & Epelbaum, J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01877.x · Cited by 51
Frankton, S., & Bloom, S. R. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90019-6 · Cited by 51
Brauch, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.12.4101 · Cited by 51
State of the art and future prospects in the management of neuroendocrine tumors.
Öberg, K. (2000) · PubMed · Cited by 50
Gucagonoma syndrome is an underdiagnosed clinical entity
Edney, J. A., Hofmann, S. C., Thompson, J. S., & Kessinger, A. (1990) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80761-5 · Cited by 50
van Eijck, C. H. J., Lamberts, S. W. J., Lemaire, L. C. J. M., Jeekel, H. J., Bosman, F. T., Reubi, J., Bruining, H. A., & Krenning, E. P. (1996) · Annals of Surgery · doi:10.1097/00000658-199608000-00002 · Cited by 50
Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma.
Leimer, M., Kurtaran, A., Smith-Jones, P. M., Raderer, M., Havlik, E., Angelberger, P., Vorbeck, F., Niederle, B., Herold, C., & Virgolini, I. J. (1998) · PubMed · Cited by 50
Gastric carcinoids: A statistical evaluation of 1094 cases collected from the literature
Soga, J. (1997) · Surgery Today · doi:10.1007/bf02388135 · Cited by 49
ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT
Perry, R. R., & Vinik, A. I. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.57 · Cited by 49
Medical Treatment of Metastasizing Carcinoid Tumors
Arnold, R. (1996) · World Journal of Surgery · doi:10.1007/s002689900031 · Cited by 49
Carcinoid of the pancreas: Clinical characteristics and morphological features
Maurer, C. A., Baer, H. U., Dyong, T., Mueller‐Garamvölgyi, E., Friess, H., Ruchti, C., Reubi, J. C., & Büchler, M. W. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00049-4 · Cited by 49
Somatostatin analogue treatment of neuroendocrine tumours
de Herder, W. W., van der Lely, A. J., & Lamberts, S. W. J. (1996) · Postgraduate Medical Journal · doi:10.1136/pgmj.72.849.403 · Cited by 48
Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotide
Scherübl, H., Wiedenmann, B., Riecken, E. O., Thomas, F., Böhme, E., & Räth, U. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90065-5 · Cited by 48
Bravo, E. L. (2002) · Cardiology in Review · doi:10.1097/00045415-200201000-00009 · Cited by 48
Soga, J. (1998) · PubMed · Cited by 47
Kaltsas, G., Mukherjee, J. J., Isidori, A. M., Kola, B., Plowman, P. N., Monson, J. P., Grossman, A. B., & BESSER, G. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01589.x · Cited by 47
Self-citationSundin, A., Eriksson, B. K., Bergström, M., Bjurling, P., Lindner, K., Öberg, K., & Långström, B. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00085-2 · Cited by 47
Rougier, P., Oliveira, J., Ducreux, M. P., Théodore, C., Kac, J., & Droz, J. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90014-5 · Cited by 47
Vasoactive intestinal polypeptide-secreting tumours: Biology and therapy
Park, S. K., O'Dorisio, M. S., & O’Dorisio, T. M. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90018-4 · Cited by 46
Kumaki, N., Kajiwara, H., Kameyama, K., DeLellis, R. A., Asa, S. L., OSAMURA, R. Y., & Takami, H. E. (2002) · Endocrine Pathology · doi:10.1385/ep:13:2:149 · Cited by 46
Krenning, E. P., Kwekkeboom, D. J., de Jong, M., Visser, T. J., Reubi, J. C., Bakker, W. H., Kooij, P. P., & Lamberts, S. W. (1994) · PubMed · Cited by 46
Bomanji, J. B., Britton, K. E., Ur, E., Hawkins, L., Grossman, A. B., & BESSER, G. M. (1993) · Nuclear Medicine Communications · doi:10.1097/00006231-199310000-00004 · Cited by 45
Self-citationKoriyama, N., Kakei, M., Yaekura, K., Okui, H., Yamashita, T., Nishimura, H., Matsushita, S., & Tei, C. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023513 · Cited by 45
Typical and atypical bronchial carcinoids
Torre, M. D., Barberis, M. C. P., Barbieri, B., Bonacina, E., & Belloni, P. A. (1989) · Respiratory Medicine · doi:10.1016/s0954-6111(89)80201-x · Cited by 45
Lehnert, H., Mundschenk, J., & Hahn, K. (2003) · KARGER eBooks · doi:10.1159/000074663 · Cited by 45
Isidori, A. M., Kaltsas, G., Frajese, V., Kola, B., Whitelocke, R. A. F., Plowman, P. N., Britton, K. E., Monson, J. P., Grossman, A. B., & BESSER, G. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8407 · Cited by 44
Self-citationNuclear Medicine Applications for Neuroendocrine Tumors
Chatal, J., Bodic, M. F. L., Kraeber‐Bodéré, F., Rousseau, C., & Resche, I. (2000) · World Journal of Surgery · doi:10.1007/s002680010213 · Cited by 44
Andersson, T., Eriksson, B. K., Lindgren, P. G., Wilander, E., & Öberg, K. (1987) · Annals of Surgery · doi:10.1097/00000658-198712000-00007 · Cited by 44
Jensen, R. T. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90016-0 · Cited by 44
Kaltsas, G., Papadogias, D., & Grossman, A. B. (2003) · KARGER eBooks · doi:10.1159/000074658 · Cited by 43
Self-citationClayman, G. L., & ElBaradie, T. S. (2003) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(02)00136-6 · Cited by 43
Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers
Ohashi, K., Tsutsumi, M., Nakajima, Y., Kobitsu, K., Nakano, H., & Konishi, Y. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8<1593::aid-cncr26>3.0.co;2-u · Cited by 43
Established Clinical Use of Octreotide and Lanreotide in Oncology
Öberg, K. (2001) · Chemotherapy · doi:10.1159/000049160 · Cited by 43
Endocrine tumors of the digestive tract and pancreas: histogenesis, diagnosis and molecular basis
Rindi, G., Villanacci, V., Ubiali, A., & Scarpa, A. (2001) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.1.3.323 · Cited by 42
A familial glucagonoma syndrome
Stacpoole, P. W., Jaspan, J., Kasselberg, A. G., Halter, S. A., Polonsky, K., Gluck, F. W., Liljenquist, J. E., & Rabin, D. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90858-5 · Cited by 42
Izumi, M., Nakanishi, Y., Takayama, K., Kimotsuki, K., Inoue, K., Wataya, H., Minami, T., & Hara, N. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1451::aid-cncr1152>3.0.co;2-z · Cited by 42
Radiopharmaceutical Treatment of Pheochromocytomas
Sisson, J. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04412.x · Cited by 42
Somatostatin Analogs in Oncology: A Look to the Future
Jenkins, S. A., Kynaston, H., Davies, N. P., BAXTER, J. N., & Nott, D. (2001) · Chemotherapy · doi:10.1159/000049168 · Cited by 42
Malignant Somatostatinoma: Clinical Features and Metabolic Studies*
Axelrod, L., Bush, M. A., Hirsch, H. J., & Loo, S. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-5-886 · Cited by 41
KIMURA, N., MIURA, W., NOSHIRO, T., MIZUNASHI, K., HANEW, K., SHIMIZU, K., WATANABE, T., SHIBUKAWA, S., SOHN, H. E., ABE, K., et al. (1997) · Endocrine Journal · doi:10.1507/endocrj.44.319 · Cited by 40
Chromogranin A, a significant prognostic factor in small cell lung cancer
Drivsholm, L., Paloheimo, L. I., & Østerlind, K. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690745 · Cited by 40
α-METHYL-p-TYROSINE IN THE MANAGEMENT OF PHÆOCHROMOCYTOMA
Jones, N. F., Walker, G., Ruthven, C. R. J., & Sandler, M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)91579-1 · Cited by 40
Sisson, J. C., Shapiro, B., Hutchinson, R., Carey, J. E., Zasadny, K. R., Zempel, S., & Normolle, D. P. (1994) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00182305 · Cited by 40
Current concepts in diagnosis and management
Strauss, J. (1981) · Plenum eBooks · Cited by 39
Takahashi, K., Ashizawa, N., Minami, T., Suzuki, S., Sakamoto, I., Hayashi, K., Tomiyasu, S., Sumikawa, K., Kitamura, K., Eto, T., et al. (1999) · Internal Medicine · doi:10.2169/internalmedicine.38.349 · Cited by 39
Complete histological regression of metastatic carcinoid tumour after treatment with octreotide
Imtiaz, K. E., Monteith, P., & Khaleeli, A. A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01126.x · Cited by 39
Gastric stem cells: an update.
Modlin, I. M., Kidd, M. S., Lye, K. D., & Wright, N. A. (2003) · The Keio Journal of Medicine · doi:10.2302/kjm.52.134 · Cited by 39
Midgut Carcinoid Tumours: CT Appearance
Sugimoto, E., Lörelius, L., Eriksson, B. K., & Öberg, K. (1995) · Acta Radiologica · doi:10.1177/028418519503600407 · Cited by 39
Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma.
Rufini, V., Salvatori, M., Garganese, M. C., Giuda, D. D., Maussier, M. L., & Troncone, L. (2000) · PubMed · Cited by 38
Bukowski, R. M., Tangen, C. M., Lee, R. S., Macdonald, J. S., Einstein, A. B., Peterson, R. F., & Fleming, T. R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.12.1914 · Cited by 38
Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris, S., & Khan, M. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080307 · Cited by 38
Shapiro, B., Sisson, J. C., Shulkin, B. L., Gross, M. D., & Zempel, S. (1995) · PubMed · Cited by 38
Treatment of Endocrine Tumors of the Pancreas
Vinik, A. I., & Moattari, A. R. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30379-7 · Cited by 38
How many pathways to pheochromocytoma?
Neumann, H. P. H., Hoegerle, S., Manz, T., BRENNER, K. R., & Iliopoulos, O. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.30207 · Cited by 37
Dramatic response of a metastatic carcinoid tumour to a combination of interferon and octreotide
Joensuu, H., Kätkä, K., & Kujari, H. P. (1992) · European Journal of Endocrinology · doi:10.1530/acta.0.1260184 · Cited by 37
Somatostatin Receptor Imaging: Predictive and Prognostic Considerations
Anthony, L. B., Martin, W., Delbeke, D., & Sandler, M. P. (2009) · Digestion · doi:10.1159/000201396 · Cited by 37
Hartley, A. G. J., Spooner, D. A., & Brunt, A. M. (2001) · Clinical Oncology · doi:10.1053/clon.2001.9290 · Cited by 37
Recent advances in systemic therapy for gastrointestinal neuroendocrine tumors
Pelley, R. J., & Bukowski, R. M. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199901000-00008 · Cited by 37
111 ln-Octreotide Scintigraphy in Oncology
Krenning, E. P., Kwekkeboom, D. J., Reubi, J. C., van Hagen, P. M., van Eijck, C. H. J., Oei, H. Y., & Lamberts, S. W. J. (2009) · Digestion · doi:10.1159/000201083 · Cited by 36
Dogliotti, L., Tampellini, M., Stivanello, M., Gorzegno, G., & Fabiani, L. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s105 · Cited by 36
Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women
Das, B. C., Gopalkrishna, V., Das, D. K., Sharma, J. K., Singh, V., & Luthra, U. K. (1993) · Cancer · doi:10.1002/1097-0142(19930701)72:1<42::aid-cncr2820720110>3.0.co;2-s · Cited by 35
The Clinical Use of Interferons in the Management of Neuroendocrine Gastroenteropancreatic Tumors
Öberg, K., Eriksson, B. K., & Janson, E. T. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17297.x · Cited by 34
Primary gastric carcinoids: A view on management
Davies, M. G., O'Dowd, G., McEntee, G., & Hennessy, T. P. J. (1990) · British journal of surgery · doi:10.1002/bjs.1800770919 · Cited by 34
Bachleitner‐Hofmann, T., Stift, A., Friedl, J., Pfragner, R., Radelbauer, K., Dubsky, P. C., Schüller, G., Benkö, T., Niederle, B., Brostjan, C., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8283 · Cited by 34
Somatostatin analogue (SMS 201-995) in patients with gastrinomas.
Vinik, A. I., Tsai, S., Moattari, A. R., & Cheung, P. S. Y. (1988) · PubMed · Cited by 34
Foregut carcinoids: A clinical and biochemical analysis
Kirshbom, P. M., Kherani, A. R., Onaitis, M. W., Hata, A., Kehoe, T. E., Feldman, C., Feldman, J. M., & Tyler, D. S. (1999) · Surgery · doi:10.1067/msy.2099.101430 · Cited by 33
Corleto, V. D., Panzuto, F., Falconi, M., Cannizzaro, R., Angeletti, S., Moretti, A., Fave, G. D., & Farinati, F. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80710-6 · Cited by 33
Pediatric malignant pheochromocytoma
Ein, S. H., Weitzman, S. S., Thorner, P. S., Seagram, C. G. F., & Filler, R. M. (1994) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(94)90799-4 · Cited by 33
Mundschenk, J., & Lehnert, H. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212001 · Cited by 33
Treatment of neuroendocrine tumors
Öberg, K. (1994) · Cancer Treatment Reviews · doi:10.1016/0305-7372(94)90016-7 · Cited by 32
Effect of Octreotide on Catecholamine Plasma Levels in Patients with Chromaff in Cell Tumors
Invitti, C., Martin, M. D., Bolla, G. B., Giraldi, F. P., Maestri, E., Leonetti, G., & Cavagnini, F. (1993) · Hormone Research · doi:10.1159/000183786 · Cited by 31
Sonographic appearance of primary small bowel carcinoid tumor
Rioux, M., Langis, P., & Naud, F. (1995) · Abdominal Imaging · doi:10.1007/bf00199642 · Cited by 31
Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinomas.
Taourel, P., Dauzat, M., Lafortune, M., Pradel, J., Rossi, M., & Bruel, J. M. (1994) · Radiology · doi:10.1148/radiology.191.1.8134569 · Cited by 31
NEUROENDOCRINE TUMORS OF THE LUNG: Pathology and Molecular Biology
Vuitch, F., Fong, K. M., Mackay, B., Minna, J. D., Gazdar, A. F., & Sekido, Y. (1997) · Chest Surgery Clinics of North America · doi:10.1016/s1052-3359(25)00775-6 · Cited by 31
Pheochromocytoma and functional paraganglioma
Roman, S. A. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00003 · Cited by 31
Primary carcinoid tumor of the testis
Frank, R. G., GERARD, P. S., Anselmo, M. T., Bennett, L., Preminger, B., & Wise, G. J. (1990) · Urologic Radiology · doi:10.1007/bf02924009 · Cited by 30
Gastrointestinal endocrine tumours: Medical management
Arnold, R., & Frank, M. (1996) · Baillière s Clinical Gastroenterology · doi:10.1016/s0950-3528(96)90021-4 · Cited by 30
Osteogenic sarcoma. Malignant fibrous histiocytoma subtype
Ballance, W. A., Mendelsohn, G., Carter, J. R., Abdul‐Karim, F. W., Jacobs, G. H., & Makley, J. T. (1988) · Cancer · doi:10.1002/1097-0142(19880815)62:4<686::aid-cncr2820620407>3.0.co;2-7 · Cited by 30
Hughes, M., Kerr, D. J., Cassidy, J., Soukop, M., McGregor, K., Blackburn, N., Yosef, H., & Kaye, S. B. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010551 · Cited by 30
Drake, W. M., Miraki‐Moud, F., Siddiqi, A., Yateman, M., Barnes, N., Camacho-Hübner, C., & Monson, J. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390532 · Cited by 30
Diagnosis and Management of Zollinger-Ellison Syndrome
Maton, P. N., Gardner, J. D., & Jensen, R. T. (1989) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30380-3 · Cited by 30
Service, F. J. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30081-5 · Cited by 30
Surgical resection of intracardiac gastrinoma
Noda, S., Norton, J. A., Jensen, R. T., & Gay, W. A. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)01205-3 · Cited by 29
Kennedy, A. S., Harrison, G. H., Mansfield, C. M., Zhou, X. J., Xu, J., & Balcer‐Kubiczek, E. K. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000820)90:4<199::aid-ijc3>3.0.co;2-c · Cited by 29
Nuclear medicine therapy of pheochromocytoma and paraganglioma.
Troncone, L., & Rufini, V. (1999) · PubMed · Cited by 29
Taal, B. G., Hoefnagel, C. A., Boot, H., Olmos, R. A. V., & Rutgers, M. (2000) · Annals of Oncology · doi:10.1023/a:1026592025862 · Cited by 28
Von Hippel-Lindau Disease: Genetic and Clinical Observations
Iliopoulos, O. (2001) · KARGER eBooks · doi:10.1159/000061052 · Cited by 27
Walther, D. J., Peter, J., & Bäder, M. (2002) · Cancer · doi:10.1002/cncr.10592 · Cited by 27
Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2
Takami, H. E. (2003) · Endocrine Pathology · doi:10.1385/ep:14:2:123 · Cited by 27
Treatment of Metastatic Pheochromocytoma and Paraganglioma With 131I-Meta-Iodobenzylguanidine (MIBG)
Kaltsas, G., Mukherjee, J. J., Foley, R., Britton, K. E., & Grossman, A. B. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000084154.02341.ad · Cited by 27
Self-citationZuetenhorst, H. J. M., Taal, B. G., Boot, H., Olmos, R. A. V., & Hoefnagel, C. A. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199910000-00014 · Cited by 26
Kaltsas, G., Putignano, Mukherjee, J. J., Satta, M. A., Lowe, D. G., Britton, K. E., Monson, J. P., Grossman, A. B., & BESSER, G. M. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00527.x · Cited by 26
Self-citationThe use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomas
Newbould, E., Ross, G. A., Dacle, J. E., Bouloux, P. M., BESSER, G. M., & Grossman, A. B. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03496.x · Cited by 26
Self-citationNeuroendocrine Tumors Metastatic to the Liver: Vascular Occlusion Therapy
Ajani, J. A., Carrasco, C. H., & Wallace, S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17298.x · Cited by 25
Carcinoid tumours of the appendix are different
Shaw, P. A. (1990) · The Journal of Pathology · doi:10.1002/path.1711620303 · Cited by 25
Raderer, M., Kurtaran, A., Scheithauer, W., Fiebiger, W., Weinlaender, G., & Oberhuber, G. (2001) · Oncology · doi:10.1159/000055311 · Cited by 25
Deregulation of genetic pathways in neuroendocrine tumors
Calender, A., Vercherat, C., Gaudray, P., & Chayvialle, J. A. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s3 · Cited by 25
Localization of insulinomas by selective intraarterial calcium injection
Fukunaga, Y., Inoue, D., & Koshiyama, H. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954070 · Cited by 24
Somatostatin analogs: Future directions
Lamberts, S. W. J., van der Lely, A. J., de Herder, W. W., & Hofland, L. J. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90098-0 · Cited by 24
Naguib, M., Cáceres, M., Thomas, C. R., Herman, T. S., & Eng, T. Y. (2002) · American Journal of Clinical Oncology · doi:10.1097/00000421-200202000-00008 · Cited by 24
Tada, K., Okuda, Y., & Yamashita, K. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023190 · Cited by 23
Imaging advances in the diagnosis of endocrine neoplasia
Scott, B. A., & Gatenby, R. A. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199801000-00007 · Cited by 23
Noshiro, T., Honma, H., Shimizu, K., Kusakari, T., WATANABE, T., Akama, H., Shibukawa, S., Miura, W., Abe, K., & Miura, Y. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.279 · Cited by 23
Role of [131I]metaiodobenzylguanidine therapy in medullary thyroid carcinoma.
Ca, H., Delprat, C. C., & Olmos, V. S. (1991) · PubMed · Cited by 23
131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma
Sakahara, H., Endo, K., Saga, T., Hosono, M., Kobayashi, H., & Konishi, J. (1994) · Annals of Nuclear Medicine · doi:10.1007/bf03165018 · Cited by 22
Nonsurgical Treatment of Advanced Malignant Neuroendocrine Pancreatic Tumors and Midgut Carcinoids
Skogseid, B. M. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0017-4 · Cited by 22
Wu, L., Dicpinigaitis, P. V., Bruckner, H. W., Manger, W. M., & Averbuch, S. D. (1994) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950220607 · Cited by 22
Krempf, M., Lumbroso, J., Mornex, R., Brendel, A., Wémeau, J.-L., Delisle, M. J., Aubert, B., Carpentier, P., Fleury-Goyon, M. C., & Gibold, C. (1991) · PubMed · Cited by 22
Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
Skinazi, F., Zins, M., Menu, Y., Bernades, P., & Ruszniewski, P. B. (1996) · PubMed · Cited by 22
Service, F. J. (1991) · PubMed Central · Cited by 22
Ectopic Luteinizing Hormone Secretion and Anovulation
Hirshberg, B., Conn, P. M., Uwaifo, G. I., Blauer, K. L., Clark, B. D., & Nieman, L. K. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022384 · Cited by 21
Radiotherapy for unresectable endocrine pancreatic carcinomas.
Tennvall, J., Ljungberg, O., Åhrén, B., Gustavsson, A., & Lo, N. (1992) · PubMed · Cited by 21
Advances in the Management of Patients with Zollinger-Ellison Syndrome
Orloff, S. L., & Debas, H. T. (1995) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)46637-5 · Cited by 21
Lewi, H., Reid, R., Mucci, B., Davidson, J., KYLE, K. F., MACPHERSON, S. G., SEMPLE, P. F., & Kaye, S. L. (1985) · British Journal of Urology · doi:10.1111/j.1464-410x.1985.tb06295.x · Cited by 21
Can susceptibility to carcinoid tumors be inherited?
Yeatman, T. J., Sharp, J. V., & Kimura, A. K. (1989) · Cancer · doi:10.1002/1097-0142(19890115)63:2<390::aid-cncr2820630232>3.0.co;2-k · Cited by 21
Salmon, S. E. (1983) · PubMed Central · Cited by 20
Long-term octreotide treatment of metastatic carcinoid tumor
Corleto, V. D., Angeletti, S., Schillaci, O., Marignani, M., Caratozzolo, M., Panzuto, F., Annibale, B., & Fave, G. D. (2000) · Annals of Oncology · doi:10.1023/a:1008398431246 · Cited by 20
The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinoma
D??RR, U., Frank‐Raue, K., Raue, F., Sautter-Bihl, M. L., GUZMAN, G., Buhr, H. J., & Bihl, H. (1993) · Nuclear Medicine Communications · doi:10.1097/00006231-199306000-00006 · Cited by 20
Shapiro, B. (1995) · PubMed · Cited by 20
Carcinoid tumour of the middle ear: case report and review of the literature.
Riddell, D., Leboldus, G. M., Joseph, M. G., & Hearn, S. (1994) · PubMed · Cited by 20
[131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
Lumbroso, J., Schlumberger, M. J., Tenenbaum, F., Aubert, B. S., Travagli, J. P., & Parmentier, C. (1991) · PubMed · Cited by 20
Yuen, M., Hughes, R. D., Heneghan, M. A., Langley, P. G., & Norris, S. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2190::aid-cncr1562>3.0.co;2-2 · Cited by 19
Antimammary carcinogenic activity of 17-alpha-ethinyl estriol
Lemon, H. M. (1987) · Cancer · doi:10.1002/1097-0142(19871215)60:12<3033::aid-cncr2820601230>3.0.co;2-a · Cited by 19
Harris, P. E., Bouloux, P. M., Wass, J. A. H., & BESSER, G. M. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00872.x · Cited by 19
Self-citationSasaki, M., Iwaoka, T., Yamauchi, J., TOKUNAGA, H., Naomi, S., Inoue, J., Oishi, S., UMEDA, T., & Sato, T. (1994) · Endocrine Journal · doi:10.1507/endocrj.41.155 · Cited by 19
Salvage Treatment After rInterferon α-2a in Advanced Neuroendocrine Tumors
Zilembo, N., Buzzoni, R., Bajetta, E., Bartolomeo, M. D., de Braud, F., Castellani, M. R., Maffioli, L. S., Celio, L., Villa, E., Lorusso, V., et al. (1993) · Acta Oncologica · doi:10.3109/02841869309083920 · Cited by 19
Chemotherapy for neuroendocrine tumours: The beatson oncology centre experience
Hatton, M. Q. F., & Reed, N. S. (1997) · Clinical Oncology · doi:10.1016/s0936-6555(97)80132-x · Cited by 19
Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.
Lewington, V. J., Ma, Z., Tristam, M., Aj, M., & Dm, A. (1991) · PubMed · Cited by 19
[131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
Ca, H., Schornagel, J. H., & Olmos, V. S. (1991) · PubMed · Cited by 19
Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
Bongers, V., de Klerk, J. M. H., Zonnenberg, B. A., de Kort, G. A. P., Lips, C. J. M., & van Rijk, P. P. (1997) · PubMed · Cited by 19
Kniffin, W. D., Spencer, S. K., Memoli, V. A., & LeMarbre, P. (1988) · Cancer · doi:10.1002/1097-0142(19881101)62:9<1899::aid-cncr2820620905>3.0.co;2-c · Cited by 18
Cardiac Malignant Pheochromocytoma with Bone Metastases.
Atsumi, A. R. A. I., Naruse, M., Naruse, K., Tanabe, A., Yoshimoto, T., Iwama, T., Kusakabe, K., Obara, T., Demura, R., & Demura, H. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.940 · Cited by 18
Zhou, Y., Wang, S., Gobl, A., & Öberg, K. (2000) · Annals of Oncology · doi:10.1023/a:1008314804492 · Cited by 18
I-123 MIBG Imaging and Intraoperative Localization of Metastatic Pheochromocytoma: A Case Report
Buhl, T., Mortensen, J., & Kjær, A. (2002) · Clinical Nuclear Medicine · doi:10.1097/00003072-200203000-00007 · Cited by 18
Janmohamed, S., & Bloom, S. R. (1997) · Postgraduate Medical Journal · doi:10.1136/pgmj.73.858.207 · Cited by 18
Treatment of metastatic carcinoid tumour with recombinant interferon alfa
Joensuu, H., Kumpulainen, E., & Gröhn, P. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90061-6 · Cited by 17
Research works printed but not linked: 3
- Krenning, 1994, Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide., Semin Oncol, 21, 6
- Janson, 2000, Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors., J Nucl Med, 41, 1514
- Bartsch, 1990, Treatment of metastatic carcinoid tumors by recombinant human interferon-α. Results from a phase II study., J Cancer Res Clin Oncol, 116, 305
Cited by
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationClinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citation
Metadata
- Authors
- Kaltsas, G. A., Besser, G. M., & Grossman, A. B.
- Affiliations
- St Bartholomew's Hospital (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 25
- Issue
- 3
- Pages
- 458-511
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2031301095
- Semantic Scholar
- b09a37699a89446c4662f1bc87eb975bf31118b7
- Cited by
- 674
- References
- 670
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 17 · 2023: 26 · 2022: 17 · 2021: 23 · 2020: 23 · 2019: 24 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 46 · 2014: 30 · 2013: 37 · 2012: 49
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- neuroendocrine tumors, diagnosis, tumor markers, endocrine syndromes, somatostatin analogues, MIBG scintigraphy, endoscopic ultrasound, interferon-alpha, chemotherapy, radionuclide therapy, multimodal therapy, quality of life
- MeSH terms
- Adrenal Gland Neoplasms, Animals, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms, Humans, Pancreatic Neoplasms, Parathyroid Neoplasms, Pituitary Neoplasms, Prognosis, Quality of Life, Sensitivity and Specificity, Somatostatin, Thyroid Neoplasms, Tomography, X-Ray Computed, Biomarkers, Tumor, Interferon-alpha, Carcinoma, Neuroendocrine, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.